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Rat, mouse and human liver microsomes and S9 fractions were
analyzed using an optimized method combining ion exchange
fractionation of digested peptides, and ultra-high performance
liquid chromatography (UHPLC) coupled to high resolution
tandem mass spectrometry (HR-MS/MS). The mass spectrometry
proteomics data have been deposited to the ProteomeXchange
Consortium (http://proteomecentral.proteomexchange.org) via the
PRIDE partner repository (Vizcaíno et al., 2013 [1]) with the dataset
identiﬁers PXD000717, PXD000720, PXD000721, PXD000731,
PXD000733 and PXD000734. Data related to the peptides (trypsin
digests only) were also uploaded to Peptide Atlas (Farrah et al.,
2013 [2]) and are available with the dataset identiﬁers PASS00407,
PASS00409, PASS00411, PASS00412, PASS00413 and PASS00414.
The present dataset is associated with a research article published
in EuPA Open Proteomics [3].
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.euprot.2015.01.003
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M. Golizeh et al. / Data in Brief 3 (2015) 95–9896Speciﬁcations tableSubject area Chemistry, biologyMore speciﬁc
subject areaProteomic analysisType of data a) Raw and processed mass spectrometry data acquired by 2D-LC–MS/MS analysis of rat, mouse, and
human liver microsomes and S9 fractions
b) Excel datasheets with identiﬁed proteins and corresponding peptides from each analyzed sampleHow data was
acquired2D-LC–MS/MS using Agilent 1200 HPLC, Shimadzu Nexera UHPLC, and AB Sciex TripleTOF 5600 mass
spectrometerData format .wiff,.wiff.scan (raw ﬁles)
.group,.xml (search ﬁles)
.mgf (peak ﬁles)
.xlsx (false-discovery rate analysis and processed results)Experimental factors No sample pretreatment applied
Experimental
featuresLiver microsomes/S9 fractions were solubilized, denatured, and subjected to a trypsin/pepsin parallel
dual-digestion. Digested peptides were fractionated using strong cation exchange (SCX) chromatography
prior to UHPLC–MS/MS with subsequent data-mining and bioinformatics analysis.Data source location Université du Québec à Montréal (UQÀM), Chemistry Department, Montréal, Que., Canada
Data accessibility The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
via the PRIDE partner repository [1] with the dataset identiﬁers PXD000717, PXD000720,
PXD000721, PXD000731, PXD000733 and PXD000734. Data related to the peptides (trypsin digests
only) were also uploaded to Peptide Atlas [2] and are available with the dataset identiﬁers
PASS00407, PASS00409, PASS00411, PASS00412, PASS00413 and PASS00414.Value of the data Liver proteins identiﬁed in microsomal and S9 fractions with high sequence coverage.
 Comprehensive list of proteotypic peptides reported for each identiﬁed protein enables more
targeted analyses.
 Cross-species analysis of rat, mouse and human liver microsomes and S9 fractions.
 Multiple-sequence alignment (MSA) analysis possible between proteins exclusively found in each species.1. Experimental design, materials and methods
Rat, mouse, and human liver microsomes or S9 fractions (0.6 mg protein, n¼2) were solubilized in
2% SDS solution (1:1 v/v ratio) and then diluted with 0.1 M ammonium bicarbonate (pH 8.5) prior to
reductive alkylation with dithiothreitol (2.5 mM) and iodoacetamide (5 mM). Additional ammonium
bicarbonate (for trypsin), or 0.2% triﬂuoroacetic acid in 20% methanol (for pepsin), was added for an
overnight digestion at a 1:50 (w/w) enzyme/protein ratio. Digests were neutralized, diluted with
water, and subjected to solid-phase extraction (SPE) on a 1 cm3 (30 mg) OASIS HLB cartridge (Waters,
Milford, MA), eluting with 100% methanol (1 ml). Eluates were evaporated to dryness under vacuum,
reconstituted in SCX buffer A (see below), and injected (100 μl, 0.5 mg protein) onto a Zorbax 300-SCX
1502.1 mm column with 5 μm (300 Å) particles (Agilent Technologies, Palo Alto, CA) using an
Agilent 1200 series HPLC equipped with a binary pump, degasser, diode array detector and fraction
collector. SCX fractionation was performed (250 μl/min) with a gradient of 0–50% B in 15 min, up to
100% B at 25 min, then held for an additional 5 min at 100% B, where buffers A and B were 10 mM
potassium dihydrogen phosphate in 25% acetonitrile (pH 2.75), and 1 M potassium chloride in buffer A
(pH 2.75), respectively. UV absorbance was monitored at 220 and 280 nm. For trypsin samples, 3 min
Table 1
Processed data from proteomic analysis of rat, mouse, and human liver microsomes and S9 fractions.
Spices Sample ID Protein data location Peptide data location
Rattus norvegicus Liver microsomes RLM Supplemental Table S1-1 Supplemental Table S2-1
Liver S9 fraction RLS Supplemental Table S1-2 Supplemental Table S2-2
Mus musculus Liver microsomes MLM Supplemental Table S1-3 Supplemental Table S2-3
Liver S9 fraction MLS Supplemental Table S1-4 Supplemental Table S2-4
Homo sapiens Liver microsomes HLM Supplemental Table S1-5 Supplemental Table S2-5
Liver S9 fraction HLS Supplemental Table S1-6 Supplemental Table S2-6
Table 2
Dataset identiﬁers of the mass spectrometry data obtained from the analysis of rat, mouse, and human liver microsomes and S9
fractions on the public proteomics repositories.
Spices Sample ID Protein dataset identiﬁer (PRIDE) Peptide dataset identiﬁer (PeptideAtlas)
Rattus norvegicus Liver microsomes RLM PXD000720 PASS00407
Liver S9 fraction RLS PXD000717 PASS00409
Mus musculus Liver microsomes MLM PXD000731 PASS00411
Liver S9 fraction MLS PXD000733 PASS00412
Homo sapiens Liver microsomes HLM PXD000721 PASS00413
Liver S9 fraction HLS PXD000734 PASS00414
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(1.0 ml) fractions were collected between 1.5 and 25.5 min. Fractions were evaporated to dryness
under vacuum and kept at 30 1C.
Dried fractions were reconstituted in 10% acetonitrile (100 μl) and injected (20 μl) onto an Aeris
PEPTIDE XB-C18 1002.1 mm column, with solid core 1.7 μm particles (100 Å) (Phenomenex,
Torrance, CA). RP-LC was performed (300 μl/min, 40 1C) on a Nexera UHPLC system (Shimadzu,
Columbia, MD) with water (A) and acetonitrile (B), both containing 0.1% formic acid with a gradient of
5% B held for 2 min, increased linearly to reach 30% B at 24 min, to 50% B at 26 min, then to 85% B at
26.5 min and held for 2 min. MS and MS/MS spectra were collected on a high-resolution hybrid
quadrupole-time-of-ﬂight (QqTOF) TripleTOF 5600 mass spectrometer (AB Sciex, Concord, Ont.)
equipped with a DuoSpray ion source in positive ion mode. The instrument performed a survey TOF-
MS acquisition from m/z 140–1250 (250 ms accumulation time), followed by MS/MS on the 15 most
intense precursor ions fromm/z 2501250 (precursors excluded for 20 s after two occurrences) using
information-dependent acquisition (IDA) with dynamic background subtraction (DBS). Each MS/MS
acquisition (m/z 80–1500) had an accumulation time of 50 ms and collision energy of 30710 V. The
total cycle time was 1.05 s.
MS/MS ﬁles were combined and searched against the UniProt protein database (www.uniprot.org,
release date 26/06/2013) by ProteinPilot software (version 4.1) using Paragon algorithm [4] using a
thorough ID search with no speciﬁed enzyme and carbamoylation as a ﬁxed cysteine modiﬁcation.
The search was performed for þ2 to þ4 charge states and MS tolerance was 0.05 Da on precursor ions
and 0.1 Da on fragment ions. All duplicates were ﬁrst processed alone, then together and ﬁnally
tryptic and peptic digest for each sample were co-processed to obtain the total number of proteins
and peptides. Proteins were identiﬁed with a 1% global false discovery rate (FDR) using a target-decoy
database search algorithm [5] in ProteinPilot Descriptive Statistics Template (version 3.001p) (www.
absciex.com/PDST). ProteinPilot Protein Alignment Template (version 2.000p) was also used for
replicate analysis. The list of UniProt accession numbers from identiﬁed proteins was uploaded to
NCBI Batch Entrez (www.ncbi.nlm.nih.gov/sites/batchentrez) to obtain the batch FASTA ﬁle, which
was subsequently submitted to ExPASy (www.expasy.org) for determination of isoelectric point and
monoisotopic molecular weight, to Phobius (phobius.sbc.su.se) [6] for prediction of integral
membrane proteins, and to GRAVY Calculator (www.gravy-calculator.de) to compute grand average
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microsomes and S9 fractions, as well as the corresponding proteotypic peptides can be found in
Supplemental Tables S1 and S2 (see Tables 1 and 2 for details).Funding sources
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2015.02.007.References
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